Cardiovascular devices

The French National Authority for Health (HAS) released new recommendations on the registration of medical devices and medical aids in the List of Reimbursable Products and Services (LPPR) following the February 2026 meetings of the National Commission for the Evaluation of Medical Devices and Health Technologies (CNEDiMTS). Favourable opinions were issued on the add-on reimbursement for six new devices and on the extension of indications for two devices, in the cardiovascular, peripheral vascular, and ENT fields.

In February 2026, the National Institute for Health and Care Excellence (NICE) published three new HealthTech Guidances (HTGs) on transcatheter tricuspid valve implantation, leadless cardiac pacemakers for bradyarrhythmia, and pulmonary artery pressure technologies for remote monitoring of chronic heart failure.

On December 3, 2025, the Swiss Federal Office of Public Health published updates to the Healthcare Benefit Ordinance (KLV/OPre), which determines coverage of medical services in Switzerland. The changes will take effect on January 1, 2026, and relate to prophylactic vaccinations, cost containment measures, and other matters. The updates are also implemented in KLV Annexes, including the List of explicitly evaluated services (Annex 1), the outpatient-before-inpatient mandate (Annex 1a), the List of Medical Aids (Annex 2, MiGeL), and the List of Analyses (Annex 3, AL).

In August 2025, Health Technology Wales (HTW) accomplished two full appraisals on long-length peripheral intravenous catheters (LPCs) for difficult intravenous access and photo-plethysmography for managing atrial fibrillation. In addition, two Med Tech-related Topic Exploration Reports were published in the radiotherapy and e-health fields.

In June 2025, Belgian INAMI/RIZIV updated the List of implants and invasive medical devices. Four new reimbursement codes were added to the List in relation to heart valve replacement. Several Nominative lists of brands were updated as well in the fields of neuromodulation, neurovascular, orthopedic, and cardiovascular.

On July 1, 2025, the revised EBM (German Uniform Evaluation Standard) catalog for the third quarter of 2025 came into force. The main changes introduced concern updates of the contents (services legends, preambles of several EBM subchapters) and the introduction of new EBM codes for the reimbursement of transmitters for telemonitoring and telemedical monitoring of implantable cardiac devices, as well as codes for the services provided within the co-funded study on low-dose pulsed ultrasound for pseudarthrosis.

On May 01, 2025, the Dutch Healthcare Authority (NZa) published the first release of the 2026 DRG package (RZ26a). Three new procedure codes, seven new supplementary payments (OZPs), one new diagnosis code, and two new DRGs will be implemented across in-vitro diagnostics, obstetrics and gynecology, neurology and neurosurgery, cardiovascular and other technology groups.

The French National Authority for Health (HAS) has released new recommendations about add-on reimbursement of medical devices and medical aids from the February 2025 meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS). Sixteen favorable opinions were published concerning the registration or modification of registration conditions/extension of indications for the medical devices in the List of Reimbursable Products and Services (LPPR). They relate to cardiovascular and peripheral vascular, neurovascular, endocrinology, interventional radiology, nephrology and urology, orthopedic devices, and medical aids.

The French National Authority for Health (HAS) has released new recommendations about add-on reimbursement of medical devices and medical aids from the January 2025 meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS). Seventeen favorable opinions were published concerning the registration or modification of registration conditions/extension of indications for the medical devices in the List of Reimbursable Products and Services (LPPR). They relate to cardiovascular, endocrine, e-health, interventional radiology, neurology and neurosurgery, orthopedic devices, and medical aids.

In December 2024, the National Institute for Health and Disability Insurance (INAMI/RIZIV) launched a new agreement (Convention) allowing reimbursement for remote monitoring of patients with chronic heart failure. It will come into force on January 1, 2025. New codes (pseudonomenclature) with fees for packages of care will be used for reimbursement. The packages include monitoring of clinical parameters by patients at home (e.g., blood pressure measurement or pulmonary artery pressure measured by an implanted sensor) and transmission of data via a health app to the remote monitoring team at the hospital.

In Q3 2024, Health Technology Wales completed three full appraisals with the publication of Evidence Appraisal Report and Guidance (AI for whole slide prostate biopsy images, AI-assisted endoscopy for gastrointestinal cancer, and Floseal in the treatment of epistaxis). Furthermore, 24 Med Tech-related Topic Exploration Reports were published concerning cardiovascular, gastrointestinal, gynecology, e-health, in-vitro diagnostics, and other areas.

The HTA body of the Tuscany Regional Healthcare issues three types of documents: full HTA reports, rapid HTA reports, and motivational forms. With regional decree 16951 of July 22, 2024, Tuscany Regional Healthcare published five new assessments and two reassessments of medical devices in the cardiovascular, peripheral vascular, surgical procedures, and obstetrics and gynecology areas.